文献速递消化系统肿瘤

临床多基因panel检测揭示早发性结直肠癌患者胚系致病变异的种族与民族差异

Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
PubMed 文献 · J Clin Oncol · 2023-06-15

该研究纳入3980例15至49岁首原发结直肠癌患者,接受14个结直肠癌易感基因胚系检测。485例(12.2%)携带胚系致病变异或可能致病变异,不同种族/民族间Lynch综合征及APC、CHEK2、MLH1、单等位MUTYH和PTEN变异频率存在差异。作者认为现有多基因panel可能不能代表多样人群的早发性结直肠癌风险,需进一步研究。

要点

  • 3980例早发性结直肠癌患者中485例(12.2%)携带胚系致病变异或可能致病变异。
  • 不同种族/民族间Lynch综合征(P=0.037)及APC、CHEK2、MLH1、单等位MUTYH和PTEN变异频率存在差异(均P<0.026)。
  • 校正模型显示,德系犹太人APC致病变异(含p.I1307K)OR为2.67,西班牙裔MLH1变异OR为8.69,均高于白人患者。

核心结论

  • 年轻结直肠癌患者的胚系遗传特征因种族/民族而异,提示现有多基因panel检测可能不能代表多样人群的早发性结直肠癌风险。
  • 需要进一步研究,通过祖先特异性基因和变异发现来优化早发性结直肠癌基因检测的基因选择,以实现公平的临床获益并减轻疾病负担的不平等。

研究设计与样本

  • 纳入15至49岁诊断为第一原发结直肠癌、自我认同为德系犹太人、亚裔、黑人、西班牙裔或白人,并由临床检测实验室对14个结直肠癌易感基因进行胚系基因检测的个体。
  • 采用卡方检验和校正性别、年龄、结直肠癌部位及原发结直肠肿瘤数量的多变量logistic回归评估种族和民族组间的变异比较。

主要发现

  • 3980例早发性结直肠癌患者中,485例(12.2%)共检出530个胚系致病或可能致病变异。
  • 按种族/民族,德系犹太人患者12.7%、亚裔患者9.5%、黑人患者10.3%、西班牙裔患者14.0%、白人患者12.4%携带胚系变异。
  • Lynch综合征(P=0.037)以及APC、CHEK2、MLH1、单等位MUTYH和PTEN变异在早发性结直肠癌患者中的频率因种族/民族而异(均P<0.026)。
  • 校正模型中,德系犹太人患者携带APC致病变异(包括p.I1307K)的比值比(OR)为2.67(95%CI 1.30至5.49;P=0.007),西班牙裔患者携带MLH1变异的OR为8.69(95%CI 2.68至28.20;P=0.0003),均高于白人患者。

临床怎么用

  • 作者认为现有多基因panel检测可能不能代表多样人群的早发性结直肠癌风险,并建议通过祖先特异性基因和变异发现优化早发性结直肠癌基因检测的基因选择,但原文未据此给出具体检测推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The early-onset colorectal cancer (EOCRC) burden differs across racial/ethnic groups, yet the role of germline genetic predisposition in EOCRC disparities remains uncharacterized. We defined the prevalence and spectrum of inherited colorectal cancer (CRC) susceptibility gene variations among patients with EOCRC by race and ethnicity. PATIENTS AND METHODS: We included individuals diagnosed with a first primary CRC between age 15 and 49 years who identified as Ashkenazi Jewish, Asian, Black, Hispanic, or White and underwent germline genetic testing of 14 CRC susceptibility genes performed by a clinical testing laboratory. Variant comparisons by racial and ethnic groups were evaluated using chi-square tests and multivariable logistic regression adjusted for sex, age, CRC site, and number of primary colorectal tumors. RESULTS: Among 3,980 patients with EOCRC, a total of 530 germline pathogenic or likely pathogenic variants were identified in 485 individuals (12.2%). By race/ethnicity, 12.7% of Ashkenazim patients, 9.5% of Asian patients, 10.3% of Black patients, 14.0% of Hispanic patients, and 12.4% of White patients carried a germline variant. The prevalence of Lynch syndrome (P = .037), as well as APC, CHEK2, MLH1, monoallelic MUTYH, and PTEN variants, varied by race/ethnicity among patients with EOCRC (all P < .026). Ashkenazim and Hispanic patients had significantly higher odds of presenting with a pathogenic APC variant, which included p.I1307K (odds ratio [OR], 2.67; 95% CI, 1.30 to 5.49; P = .007) and MLH1 variant (OR, 8.69; 95% CI, 2.68 to 28.20; P = .0003), respectively, versus White patients in adjusted models. CONCLUSION: Germline genetic features differed by race/ethnicity in young patients with CRC, suggesting that current multigene panel tests may not be representative of EOCRC risk in diverse populations. Further study is needed to optimize genes selected for genetic testing in EOCRC via ancestry-specific gene and variant discovery to yield equitable clinical benefits for all patients and to mitigate inequities in disease burden.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Seagle HM, Keller SR, Tavtigian SV, et al. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer. J Clin Oncol. 2023. PMID: 37319387. doi:10.1200/JCO.22.02378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。